Developing Novel Drugs To Treat Autism
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Hundreds of genetic variants are being associated with the group of neurodevelopmental conditions known as autism spectrum disorders, opening the way for mechanism-based therapies that target synaptic alterations related to those genes and treat the symptoms or even alter the course of those disorders.